Tirzepatide eligibility in NYC

This page focuses on who may qualify, what usually blocks a start, and what a real candidacy review should cover before a weight-loss prescription is written.

Tirzepatide for weight management is generally reviewed for adults with obesity, or adults with overweight plus a weight-related medical condition, alongside a reduced-calorie diet and increased physical activity. Some adults with obesity and moderate to severe obstructive sleep apnea may also fall within current FDA-approved use. The real decision still depends on medical history, current medications, GI tolerance, thyroid-cancer risk factors, and whether another GLP-1 path already makes more sense.

Many major insurance plans are accepted for eligible medical weight-loss visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Tirzepatide medication coverage is separate from visit coverage and often depends on the prescription benefit, prior authorization rules, employer exclusions, and current pharmacy fulfillment.